| pubmed-article:8288498 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8288498 | lifeskim:mentions | umls-concept:C0004611 | lld:lifeskim |
| pubmed-article:8288498 | lifeskim:mentions | umls-concept:C0004613 | lld:lifeskim |
| pubmed-article:8288498 | lifeskim:mentions | umls-concept:C0949665 | lld:lifeskim |
| pubmed-article:8288498 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:8288498 | lifeskim:mentions | umls-concept:C1697858 | lld:lifeskim |
| pubmed-article:8288498 | lifeskim:mentions | umls-concept:C0441669 | lld:lifeskim |
| pubmed-article:8288498 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:8288498 | pubmed:dateCreated | 1994-2-22 | lld:pubmed |
| pubmed-article:8288498 | pubmed:abstractText | Agar dilution and microbroth dilution methods appear equally acceptable for susceptibility testing of anaerobes against temafloxacin and ciprofloxacin. Most major discrepancies occurred with strains whose MIC was near the breakpoint. These results suggest that method variation will not be a significant factor in the susceptibility testing of anaerobic bacteria against other fluoroquinolone agents. | lld:pubmed |
| pubmed-article:8288498 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8288498 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8288498 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8288498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8288498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8288498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8288498 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8288498 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:8288498 | pubmed:issn | 0305-7453 | lld:pubmed |
| pubmed-article:8288498 | pubmed:author | pubmed-author:EdmistonC ECE | lld:pubmed |
| pubmed-article:8288498 | pubmed:author | pubmed-author:CondonR ERE | lld:pubmed |
| pubmed-article:8288498 | pubmed:author | pubmed-author:KrepelC JCJ | lld:pubmed |
| pubmed-article:8288498 | pubmed:author | pubmed-author:GohrC MCM | lld:pubmed |
| pubmed-article:8288498 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8288498 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:8288498 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8288498 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8288498 | pubmed:pagination | 571-5 | lld:pubmed |
| pubmed-article:8288498 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8288498 | pubmed:meshHeading | pubmed-meshheading:8288498-... | lld:pubmed |
| pubmed-article:8288498 | pubmed:meshHeading | pubmed-meshheading:8288498-... | lld:pubmed |
| pubmed-article:8288498 | pubmed:meshHeading | pubmed-meshheading:8288498-... | lld:pubmed |
| pubmed-article:8288498 | pubmed:meshHeading | pubmed-meshheading:8288498-... | lld:pubmed |
| pubmed-article:8288498 | pubmed:meshHeading | pubmed-meshheading:8288498-... | lld:pubmed |
| pubmed-article:8288498 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8288498 | pubmed:articleTitle | Microbroth versus agar dilution for susceptibility testing of fluoroquinolones and other agents against anaerobic bacteria. | lld:pubmed |
| pubmed-article:8288498 | pubmed:affiliation | Department of Surgery, Medical College of Wisconsin, Milwaukee 53226. | lld:pubmed |
| pubmed-article:8288498 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8288498 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8288498 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
